New pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-one hybrids linked to arene units: synthesis of potential MRSA, VRE, and COX-2 inhibitors
- 1 November 2021
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 99 (11), 900-909
- https://doi.org/10.1139/cjc-2021-0121
Abstract
In the current study, we reported the tandem synthesis of two series of arene-linked pyrimidinone hybrids with related fused thieno[2,3-b]pyridine moiety. The target hybrids were prepared, in moderate to excellent yields, by the reaction of a ternary mixture of the appropriate of 3-aminothieno[2,3-b]pyridine-2-carboxylate, DMF-DMA, and a series of aryl amines in dioxane at 110 °C for 8 h. The antibacterial activity of the new hybrids was estimated against six susceptible ATCC strains. Hybrids 5g and 7g, linked to a sulfonamide unit, showed the best efficacy against S. aureus and E. faecalis strains with minimum inhibitory concentration (MIC) values of 1.7–1.8 μM, which exceed ciprofloxacin. Furthermore, some of new hybrids were examined as potential inhibitors of four different MRSA and VRE strains. Hybrids 5g and 7g demonstrated more potent efficacy than linezolid against MRSA strains with MIC values of 3.6/3.4 and 1.8/1.7 μM against ATCC:33591 and ATCC:43300 strains, respectively. The prior hybrids displayed a comparable efficacy with linezolid against VRE strains with MIC values of 7.3/6.9 and 3.6/3.4 μM against ATCC:51299 and ATCC:51575 strains, respectively. Additionally, some of the new hybrids were examined as potential COX-2 inhibitors using the reference celecoxib (IC50 of 0.117 µM). Hybrid 7g revealed more potent inhibitory efficacy than celecoxib with IC50 of 0.112 µM, whereas hybrid 5g showed almost inhibitory activity equivalent to celecoxib with IC50 of 0.121 µM. Molecular docking was performed to predict the possible binding interactions between hybrids 5g and 7g with the target COX-2 enzyme.Keywords
This publication has 71 references indexed in Scilit:
- Synthesis and Antimicrobial Activity of Some New Pyrimidinone and Oxazinone Derivatives Fused with Thiophene Rings Using 2-Chloro-6-ethoxy-4-acetylpyridine as Starting MaterialMolecules, 2012
- DSX: A Knowledge-Based Scoring Function for the Assessment of Protein–Ligand ComplexesJournal of Chemical Information and Modeling, 2011
- Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 InhibitorsJournal of Medicinal Chemistry, 2010
- Neutral red uptake assay for the estimation of cell viability/cytotoxicityNature Protocols, 2008
- Small molecule inhibitors of E. coli primase, a novel bacterial targetBioorganic & Medicinal Chemistry Letters, 2007
- Pyridine-2(1H)-thione in Heterocyclic Synthesis: Synthesis of Some New Nicotinic Acid Ester, Thieno[2, 3-b]pyridine, Pyrido[3′, 2′: 4, 5]thieno [3, 2-d]pyrimidine, and Thiazolylpyrazolo[3, 4-b]pyridine DerivativesPhosphorus, Sulfur, and Silicon and the Related Elements, 2006
- Structure−Activity Relationship of Triazafluorenone Derivatives as Potent and Selective mGluR1 AntagonistsJournal of Medicinal Chemistry, 2005
- A Critical Assessment of Docking Programs and Scoring FunctionsJournal of Medicinal Chemistry, 2005
- Pyrimidinone antibiotics—heterocyclic analogues with improved antibacterial spectrumBioorganic & Medicinal Chemistry Letters, 2003
- Formamidine as a Versatile Protecting Group for Primary Amines: A Mild Procedure for Hydrolytic RemovalSynthetic Communications, 1994